Results and presentations


Latest presentations

2016

2015

Majority stake investment in Acerta Pharma

Materials available: 2

Late-stage pipeline call

Materials available: 1

American College of Rheumatology (ACR) 2015 Investor science conference call

Materials available: 2

2015 American Society of Clinical Oncology (ASCO) Annual Meeting Investor science event

Materials available : 2

AstraZeneca Mölndal

Materials available : 1

American College of Cardiology (ACC) 2015 Investor science conference call

Materials available : 1

Investor Relations presentation

Materials available: 1

33rd J.P. Morgan Healthcare Conference

Materials available : 1

2014

Strategic Transaction with Almirall in Respiratory Disease

Materials available : 1

2014 American Society of Clinical Oncology (ASCO) Annual Meeting

Materials available : 1

American Thoracic Society (ATS) 2014 AstraZeneca Analyst briefing

Materials available : 3

AstraZeneca strategy update

Materials available : 2

2013

Global diabetes alliance analyst call

Materials available : 2

MedImmune R&D Roadshow

Materials available : 1

Third quarter and nine months results 2013

Materials available : 2

2012

Fostamatinib analyst briefing

Materials available : 2

Fostamatinib analyst briefing video

Play Video

Naloxegol educational presentation

Materials available : 2

Naloxegol educational presentation video

Play Video


 

  • Annual reports

    Our Annual Report provides a wide range of information about our global business.

  • Our Pipeline

    Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.

  • Shareholder FAQs

    Answers to frequently asked shareholder questions.